Login

The mission to digitise, democratise, and decarbonise supply chains|Shereen Zarkani,Managing Partner and Head of Maersk Growth,Maersk Growth 00:10:00

Share On Facebook Share On Twitter

Previously the VP and Global Head of Maersk

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Exploring the intricacies of real estate dynamics | Christophe Kullmann, CEO, Covivio Hotels SCA.
00:10:00
Transformative Strategies in Asset Management: An Interview with Kumar, CEO of Axis Mutual Fund | B.Gopkumar, CEO , Axis Mutual Fund.
00:10:00
Green revolution in energy: Lower bills at month-end, stronger energy independence, and increased security discussed on 'Litgrid' podcast 'Future Energy' with energy expert Martynas Nagevičius and Litgrid's Head of Strategy Department Liutauras Varanaviči
00:10:00
"Transforming Financial Advisory Practices: The Country Club Mindset | Scott Keffer, Author and Wealth Planner"
00:10:00
Selling a Company is Personal|Michael Bloch,Partner,Quiet Capital
00:10:00
Rich Handler on Leadership, Mentorship, and Family Values
00:00:00
Gerald Solensky Jr., Chairman and CEO of Zomedica Pharmaceuticals Corp.
00:00:00
Dr. Richard Lipscombe, Managing Director, Proteomics International Laboratories Lt
00:10:00
Per Lekander: Visionary Fund Manager at Lansdowne Partners
00:00:00
Cardiologist |Simin Gharib Lee, MD, MBA
00:10:00
Trakm8 AGM and Technology Roadshow 2017: Direct Line Group's Dan Freedman Presents Innovation Insights |John Watkins is Chairman and CEO OF Trakm8 AGM
00:10:00
CEO Steve McQuillan & CFO Stephen King Discuss Avingtrans' Upbeat H1 Results | Steve McQuillan - Chief Executive Officer of Avingtrans

© 2017 - Neuhu+